Agilex is pleased to introduce Mallory Jolly as our new Senior Business Development Director to the East Coast of the United State...
Agilex Demystifies the Rapidly Evolving Landscape of Drug Development Post-Covid, the field of bioanalysis has undergone signif...
As Agilex Biolabs continues its global expansion and corporate evolution as part of the Healius network, Stephen McIntyre has been selected to take the position of Chief Executive Officer.
ddPCR technology provides an opportunity to streamline research and development processes, saving time and money. Digital dropl...
Small and large molecule drug development often necessitates distinct analytical methodologies. Agilex has extensive experience de...
Agilex has extensive experience developing and validating like-binding assays for specific immune-oncology therapeutics. From a...
Come to Our EBF Session in Barcelona to Hear how Agilex Can Make Your PK Data SPARCL SPARCL stands for Spatial Proximity Analyt...
How do Australia's streamlined regulatory process and global tax incentive apply to your toxicology studies? There are many ben...
As Agilex Biolabs continues its global expansion and corporate evolution as part of the Healius network, Stephen McIntyre has been selected to take the position of Chief Executive Officer.
by Holly Stefl, Chief Commercial Officer It is with much enthusiasm that Agilex Biolabs introduces its newest Senior Developmen...
